Tango Therapeutics, Inc. ( TNGX) - Key Metrics
TNGX Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$0.37 | -$0.26 | -$0.26 |
| 2026Q1 | $0 | -$0.32 | -$0.31 | -$0.31 |
| 2025Q4 | $0 | -$0.33 | -$0.26 | -$0.26 |
| 2025Q3 | $0.48 | $0.14 | -$0.28 | -$0.28 |
| 2025Q2 | $0.03 | -$0.35 | -$0.33 | -$0.34 |
TNGX Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -21.12 |
| 2026Q1 | 0% | -16.34 |
| 2025Q4 | 0% | -7.38 |
| 2025Q3 | 0% | 15 |
| 2025Q2 | 0% | -3.66 |
TNGX
Price: $25.60
52 week price:
Earnings Per Share: -0.82 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 179400
Market Capitalization: 4.3 billion